Items where Author is "Johnston, V"
Up a level |
Number of items: 12.
Bibliographic data only
Fink, D;
Wani, RS;
Johnston, V;
(2018)
Fever in the returning traveller.
BMJ (Clinical research ed), 360.
j5773.
ISSN 0959-8138
DOI: https://doi.org/10.1136/bmj.j5773
Full text not available from this repository.
Johnston, V;
Grant, AD;
(2003)
Tuberculosis in travellers.
Journal of Travel Medicine and Infectious Disease (1).
pp. 205-212.
http://researchonline.lshtm.ac.uk/id/eprint/14606
Full text not available from this repository.
Johnston, V;
Stockley, JM;
Dockrell, D;
Warrell, D;
Bailey, R;
Pasvol, G;
Klein, J;
Ustianowski, A;
Jones, M;
Beeching, NJ;
+5 more...
Brown, M;
Chapman, AL;
Sanderson, F;
Whitty, CJ;
British Infection Society and the Hospital for Tropical Diseases;
(2009)
Fever in returned travellers presenting in the United Kingdom: recommendations for investigation and initial management.
The Journal of infection, 59 (1).
pp. 1-18.
ISSN 0163-4453
DOI: https://doi.org/10.1016/j.jinf.2009.05.005
Full text not available from this repository.
Johnston, VJ;
Grant, AD;
(2003)
Tuberculosis in travellers.
Travel medicine and infectious disease, 1 (4).
pp. 205-12.
ISSN 1477-8939
http://researchonline.lshtm.ac.uk/id/eprint/7796
Full text not available from this repository.
Johnston, VJ;
Mabey, DC;
(2008)
Global epidemiology and control of Trichomonas vaginalis.
Current opinion in infectious diseases, 21 (1).
pp. 56-64.
ISSN 0951-7375
DOI: https://doi.org/10.1097/QCO.0b013e3282f3d999
Full text not available from this repository.
Public
Hoffmann, CJ;
Ledwaba, J;
Li, JF;
Johnston, V;
Hunt, G;
Fielding, KL;
Chaisson, RE;
Churchyard, GJ;
Grant, AD;
Johnson, JA;
+2 more...
Charalambous, S;
Morris, L;
(2013)
Resistance to tenofovir-based regimens during treatment failure of subtype C HIV-1 in South Africa.
Antiviral therapy, 18 (7).
pp. 915-20.
ISSN 1359-6535
DOI: https://doi.org/10.3851/IMP2652
Johnston, V;
Cohen, K;
Wiesner, L;
Morris, L;
Ledwaba, J;
Fielding, KL;
Charalambous, S;
Churchyard, G;
Phillips, A;
Grant, AD;
(2013)
Viral suppression following switch to second-line antiretroviral therapy: associations with NRTI resistance and 'sub-therapeutic' drug concentrations prior to switch.
The Journal of infectious diseases, 209 (5).
pp. 711-20.
ISSN 0022-1899
DOI: https://doi.org/10.1093/infdis/jit411
Johnston, V;
Fielding, K;
Charalambous, S;
Mampho, M;
Churchyard, G;
Phillips, A;
Grant, AD;
(2012)
Second-line antiretroviral therapy in a workplace and community-based treatment programme in South Africa: determinants of virological outcome.
PLoS One, 7 (5).
e36997.
ISSN 1932-6203
DOI: https://doi.org/10.1371/journal.pone.0036997
Johnston, V;
Fielding, KL;
Charalambous, S;
Churchyard, G;
Phillips, A;
Grant, AD;
(2012)
Outcomes following virological failure and predictors of switching to second-line antiretroviral therapy in a South African treatment program.
Journal of acquired immune deficiency syndromes (1999), 61 (3).
pp. 370-80.
ISSN 1525-4135
DOI: https://doi.org/10.1097/QAI.0b013e318266ee3f
Kranzer, K;
Govindasamy, D;
Ford, N;
Johnston, V;
Lawn, SD;
(2012)
Quantifying and addressing losses along the continuum of care for people living with HIV infection in sub-Saharan Africa: a systematic review.
J Int AIDS Soc, 15 (2).
p. 17383.
ISSN 1758-2652
DOI: https://doi.org/10.7448/IAS.15.2.17383
Post, FA;
Szubert, AJ;
Prendergast, AJ;
Johnston, V;
Lyall, H;
Fitzgerald, F;
Musiime, V;
Musoro, G;
Chepkorir, P;
Agutu, C;
+63 more...
Mallewa, J;
Rajapakse, C;
Wilkes, H;
Hakim, J;
Mugyenyi, P;
Walker, AS;
Gibb, DM;
Pett, SL;
Reduction of EArly mortaLITY in HIV-infected adults and children;
, COLLABORATORS;
Gibb, D;
Thomason, M;
Walker, AS;
Pett, S;
Szubert, A;
Griffiths, A;
Wilkes, H;
Rajapakse, C;
Spyer, M;
Prendergast, A;
Klein, N;
Looy, NV;
Little, E;
Fairbrother, K;
Cowan, F;
Seeley, J;
Bernays, S;
Kawuma, R;
Mupambireyi, Z;
Kyomuhendo, F;
Nakalanzi, S;
Peshu, J;
Ndaa, S;
Chabuka, J;
Mkandawire, N;
Matandika, L;
Kapuya, C;
Weller, I;
Malianga, E;
Mwansambo, C;
Miiro, F;
Elyanu, P;
Bukusi, E;
Katabira, E;
Mugurungi, O;
Gibb, D;
Hakim, J;
Etyang, A;
Mugyenyi, P;
Mallewa, J;
Peto, T;
Musoke, P;
Matenga, J;
Phiri, S;
Lyall, H;
Johnston, V;
Fitzgerald, F;
Post, F;
Ssali, F;
Prendergast, A;
Arenas-Pinto, A;
Turkova, A;
Bamford, A;
(2018)
Causes and Timing of Mortality and Morbidity Among Late Presenters Starting Antiretroviral Therapy in the REALITY Trial.
Clinical infectious diseases, 66 (suppl_).
S132-S139.
ISSN 1058-4838
DOI: https://doi.org/10.1093/cid/cix1141
Stockdale, AJ;
Saunders, MJ;
Boyd, MA;
Bonnett, LJ;
Johnston, V;
Wandeler, G;
Schoffelen, AF;
Ciaffi, L;
Stafford, K;
Collier, AC;
+2 more...
Paton, NI;
Geretti, AM;
(2017)
Effectiveness of protease inhibitor/nucleos(t)ide reverse transcriptase inhibitor-based second-line antiretroviral therapy for the treatment of HIV-1 infection in sub-Saharan Africa: systematic review and meta-analysis.
Clinical infectious diseases.
ISSN 1058-4838
DOI: https://doi.org/10.1093/cid/cix1108